Company Overview of H3 Biomedicine Inc.
H3 Biomedicine Inc., a biopharmaceutical company, is engaged in the discovery and development of small-molecule drugs to treat cancer. H3 Biomedicine Inc. has a strategic collaboration with Selvita S.A. The company was founded in 2010 and is based in Cambridge, Massachusetts. H3 Biomedicine Inc. operates as a subsidiary of Eisai Inc.
300 Technology Square
Cambridge, MA 02139
Founded in 2010
Key Executives for H3 Biomedicine Inc.
H3 Biomedicine Inc. Key Developments
Similar Private Companies By Industry
|VivaCeuticals, Inc.||United States|
|Velocity Pharmaceutical Development, LLC||United States|
|Sopherion Therapeutics, LLC||United States|
|NanoVec, Inc.||United States|
|VSL Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact H3 Biomedicine Inc., please visit www.h3biomedicine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.